DK40385D0 - Antitumor-farmaceutiske praeparater og fremgangsmaader til behandling af tumorer under anvendelse af (alfa,omega-bis-(disubstitueret phosphino)hydrocarbon)diguld(i)-,diguld(iii)-, disoelv(i)- og dikobber(i)-derivater - Google Patents

Antitumor-farmaceutiske praeparater og fremgangsmaader til behandling af tumorer under anvendelse af (alfa,omega-bis-(disubstitueret phosphino)hydrocarbon)diguld(i)-,diguld(iii)-, disoelv(i)- og dikobber(i)-derivater

Info

Publication number
DK40385D0
DK40385D0 DK40385A DK40385A DK40385D0 DK 40385 D0 DK40385 D0 DK 40385D0 DK 40385 A DK40385 A DK 40385A DK 40385 A DK40385 A DK 40385A DK 40385 D0 DK40385 D0 DK 40385D0
Authority
DK
Denmark
Prior art keywords
diguld
omega
bis
hydrocarbon
iii
Prior art date
Application number
DK40385A
Other languages
English (en)
Other versions
DK40385A (da
Inventor
David Taylor Hill
Randall Keith Johnson
Christopher Kevin Mirabelli
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of DK40385D0 publication Critical patent/DK40385D0/da
Publication of DK40385A publication Critical patent/DK40385A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C07F9/5027—Polyphosphines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C07F9/5045—Complexes or chelates of phosphines with metallic compounds or metals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK40385A 1984-02-01 1985-01-29 Antitumor-farmaceutiske praeparater og fremgangsmaader til behandling af tumorer under anvendelse af (alfa,omega-bis-(disubstitueret phosphino)hydrocarbon)diguld(i)-,diguld(iii)-, disoelv(i)- og dikobber(i)-derivater DK40385A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57565084A 1984-02-01 1984-02-01

Publications (2)

Publication Number Publication Date
DK40385D0 true DK40385D0 (da) 1985-01-29
DK40385A DK40385A (da) 1985-08-02

Family

ID=24301170

Family Applications (1)

Application Number Title Priority Date Filing Date
DK40385A DK40385A (da) 1984-02-01 1985-01-29 Antitumor-farmaceutiske praeparater og fremgangsmaader til behandling af tumorer under anvendelse af (alfa,omega-bis-(disubstitueret phosphino)hydrocarbon)diguld(i)-,diguld(iii)-, disoelv(i)- og dikobber(i)-derivater

Country Status (9)

Country Link
EP (1) EP0151046B1 (da)
JP (1) JPS60188322A (da)
AT (1) ATE43967T1 (da)
AU (1) AU572949B2 (da)
CA (1) CA1238854A (da)
DE (1) DE3570981D1 (da)
DK (1) DK40385A (da)
IE (1) IE850226L (da)
ZA (1) ZA85755B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH21350A (en) * 1984-06-04 1987-10-13 Smithkline Beckman Corp Tumor cell growth imhibiting pharmaceutical compositions containing phosphino-hydrocarbon-gold, silver or copper complexes
US5037812A (en) * 1985-04-02 1991-08-06 Smithkline Beckman Corporation Tumor cell growth-inhibiting pharmaceutical compositions containing phosphino-hydrocarbon-gold, silver or copper complexes
US4716230A (en) * 1985-04-16 1987-12-29 Smithkline Beckman Corporation Certain bis(di-2 or 4-pyridyl-phosphino) alkanes #10 having anti-tumor properties
DK166686A (da) * 1985-04-16 1986-10-17 Smithkline Beckman Corp Phosphinforbindelser, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse forbindelser
US4902675A (en) * 1985-05-16 1990-02-20 Smithkline Beckman Corporation "2-pyridyl and 4-pyridyl phosphine gold (I) anti tumor complexes"
EP0202854A3 (en) * 1985-05-20 1988-01-13 Smithkline Beecham Corporation Phosphine gold compounds
US4698422A (en) * 1985-05-20 1987-10-06 Smithkline Beckman Corporation Triphos and tetraphos gold compounds and ligands
NL8502929A (nl) * 1985-10-25 1987-05-18 Tno Groep viii-overgangsmetaal-complexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijke groep viii-overgangsmetaal-complex voor de behandeling van kanker, alsmede aldus verkregen gevormd geneesmiddel.
US4758589A (en) * 1985-12-23 1988-07-19 Smithkline Beckman Corporation Tetraphosphine-coordinated gold(I) complexes
US4764509A (en) * 1986-02-21 1988-08-16 Smithkline Beckman Corporation Pharmaceutical compositions containing di-gold phosphine
WO1995014703A1 (en) * 1993-11-24 1995-06-01 Luminis Pty. Ltd. Triorganophosphinegold (i) thionucleobases with anti-tumor activity
WO2001077121A1 (en) * 2000-04-10 2001-10-18 National University Of Singapore Gold complexes
US6774254B2 (en) 2000-04-10 2004-08-10 National University Of Singapore Gold complexes
DE10300097A1 (de) * 2003-01-07 2004-07-22 Bayer Ag Kupfer-Komplexe und ihre Verwendung
WO2009074305A1 (de) * 2007-12-13 2009-06-18 Biosphings Ag Gold-xanthogenate und diese enthaltende arzneimittel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3661959A (en) * 1970-07-30 1972-05-09 Du Pont Method of making organogold chloride complexes
US3676554A (en) * 1970-10-30 1972-07-11 Smith Kline French Lab Anti-arthritic compositions comprising phosphine or phosphite gold halide complexes and methods of producing anti-arthritic activity
PH21350A (en) * 1984-06-04 1987-10-13 Smithkline Beckman Corp Tumor cell growth imhibiting pharmaceutical compositions containing phosphino-hydrocarbon-gold, silver or copper complexes

Also Published As

Publication number Publication date
JPS60188322A (ja) 1985-09-25
EP0151046A3 (en) 1985-08-21
IE850226L (en) 1985-08-01
EP0151046A2 (en) 1985-08-07
EP0151046B1 (en) 1989-06-14
DE3570981D1 (en) 1989-07-20
AU572949B2 (en) 1988-05-19
AU3812685A (en) 1985-08-29
CA1238854A (en) 1988-07-05
ATE43967T1 (de) 1989-06-15
ZA85755B (en) 1986-05-28
DK40385A (da) 1985-08-02

Similar Documents

Publication Publication Date Title
DK40385D0 (da) Antitumor-farmaceutiske praeparater og fremgangsmaader til behandling af tumorer under anvendelse af (alfa,omega-bis-(disubstitueret phosphino)hydrocarbon)diguld(i)-,diguld(iii)-, disoelv(i)- og dikobber(i)-derivater
Hendry et al. The constant low oxygen concentration in all the target cells for mouse tail radionecrosis
ES8205231A1 (es) Procedimiento para preparar complejos de platino (iv)-diami-na
DK0612248T3 (da) Præparat, der indeholder cisplatin og topotecan som antitumormiddel
JO1176B1 (en) Organic platinum compound, method of preparation and use in the treatment of malignant tumors
ES2038724T3 (es) Procedimiento para preparar derivados de 2-nitroimidazol utiles como radiosensibilizadores para celulas tumorales hipoxicas.
DE3376295D1 (en) Pharmaceutical composition containing adenosine derivatives for use in treating tumours
SE8602743L (sv) Bruksferdiga injektionslosningar innehallande en antitumorantracyklinglykosid
DK197286A (da) Terapeutiske praeparater til detektering og/eller behandling af pattedyrtumorer
DE69232596D1 (de) Inhibitor von nebenwirkungen zur krebstherapy
HUT68876A (en) Pharmaceutical composition for treating tumours, containing creatine phosphate or phospho-enol-pyruvic acid
KR930700163A (ko) 연조직 종양의 치료 및/또는 진단 방법
GR75683B (da)
ATE76579T1 (de) Interferon-zusammensetzungen.
ES2134778T3 (es) Bistriazenos como agentes quimioterapeuticos.
DE3776154D1 (de) 1,2-diaminocyclohexan-platin-komplexe mit antitumor-wirkung.
PT100111A (pt) Composicao para o tratamento de um mamifero sofrendo de doenca proliferativa dapele, benigna ou maligna, compreendendo um analogo de somatostatina
US4695449A (en) Composition and method for treatment of melanomas
SE8103404L (sv) Tennforeningar, sett att framstella dem, sett att framstella ett lekemedelspreparat under anvendning av en dylik tennforening for behandling av cancer samt det pa sa sett erhallna lekemedelspreparatet
GR880100589A (en) Metalloporfyrines for the inversion of the toxic activity for the tumors treatment
ATE87314T1 (de) Platin-arzneimittel.
IT1162938B (it) Composizione per la cura dei tumori maligni in particolare sugli animali
Ono et al. The dose planning of BNCT for brain tumors
GB1352414A (en) Histidine derivatives
ES2141114T3 (es) Bistriazenos utilizados como agentes quimioterapeuticos.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment